Cargando…

Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer

BACKGROUND: The aim of this study was to evaluate efficacy of various fertility-preservative treatments with progestin and analyze prognostic factors in Stage 1A of endometrial cancer. MATERIALS AND METHODS: This retrospective study involved four Korean university hospitals. Data were collected from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roh, Hyun Jin, Yoon, Hyung Joon, Jeong, Dae Hoon, Lee, Tae Hwa, Kwon, Byung Su, Suh, Dong Soo, Kim, Ki Hyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384012/ https://www.ncbi.nlm.nih.gov/pubmed/34484380 http://dx.doi.org/10.4103/jrms.JRMS_103_20

Ejemplares similares

Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?
por: Baek, Ji Sun, et al.
Publicado: (2016)

Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer
por: Falcone, Francesca, et al.
Publicado: (2017)

Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
por: Kim, Mi Kyoung, et al.
Publicado: (2020)

Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
por: Huang, Haipeng, et al.
Publicado: (2022)

Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
por: Newtson, A.M., et al.
Publicado: (2017)

Fertility preservation in breast cancer with oral progestin: is it an option? A pilot study
por: de Oliveira, Renato, et al.
Publicado: (2021)

Preoperative Haematologic Markers for the Differentiation of Endometrial Cancer from Benign Endometrial Lesions in Postmenopausal Patients with Endometrial Masses
por: Song, Yong Jung, et al.
Publicado: (2023)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
por: Nwanodi, Oroma
Publicado: (2017)

Progestin-primed ovarian stimulation for fertility preservation in women with cancer: A comparative study
por: Filippi, Francesca, et al.
Publicado: (2023)

Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment
por: Zhou, Shuang, et al.
Publicado: (2021)

Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
por: Mitsuhashi, Akira, et al.
Publicado: (2019)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
por: Mathieu d’Argent, Emmanuelle, et al.
Publicado: (2020)

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
por: Shao, Fengping, et al.
Publicado: (2023)

Fertility preservation for patients with breast cancer: The Korean Society for Fertility Preservation clinical guidelines
por: Kim, Hoon, et al.
Publicado: (2017)

Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma
por: Jung, In Kook, et al.
Publicado: (2014)

The Perspectives of Fertility Preservation in Women with Endometrial Cancer
por: Knez, Jure, et al.
Publicado: (2021)

A fertility-sparing surgery in lymphoepithelioma-like carcinomas of the uterine cervix: A case report
por: Kim, So Hee, et al.
Publicado: (2022)

Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer
por: Ronsini, Carlo, et al.
Publicado: (2022)

Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review
por: Kwon, Byung Su, et al.
Publicado: (2019)

Oocyte Cryostorage to Preserve Fertility in Oncological Patients
por: Revelli, Alberto, et al.
Publicado: (2012)

The importance of the urologist in male oncology fertility preservation
por: Micol, Lionel A., et al.
Publicado: (2022)

Fertility-preservation in endometrial cancer: is it safe? Review of the literature
por: Carneiro, Márcia Mendonça, et al.
Publicado: (2016)

Fertility preservation in women with cervical, endometrial or ovarian cancers
por: Feichtinger, Michael, et al.
Publicado: (2016)

Fertility Preservation in Endometrial Cancer—Treatment and Molecular Aspects
por: Schubert, Melanie, et al.
Publicado: (2023)

The association between expression of p53 and aggressiveness of serous adenocarcinoma of the uterine cervix
por: Lee, Sul, et al.
Publicado: (2020)

Response to comment on: Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
Publicado: (2020)

The Oncology Association of Bosnia and Herzegovina’s recommendations for fertility preservation in oncologic patients
por: Cerić, Timur, et al.
Publicado: (2022)

Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis
por: Li, Miaomiao, et al.
Publicado: (2019)

Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions
por: Houshdaran, Sahar, et al.
Publicado: (2020)

Identification of Genes and Pathways Differentially Expressed in Progestin Responsive Endometrial Cancer and Hyperplasia
por: Gertz, Jay, et al.
Publicado: (2021)

Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
por: Cui, Yunxia, et al.
Publicado: (2021)

Letter to editor in response to: Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
Publicado: (2020)

Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma
por: Kwon, Byung Su, et al.
Publicado: (2018)

Preserving fertility in young patients with endometrial cancer: current perspectives
por: Kalogera, Eleftheria, et al.
Publicado: (2014)

Fertility preservation in endometrial cancer patients: options, challenges and perspectives
por: Terzic, Milan, et al.
Publicado: (2020)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
por: Guan, Jun, et al.
Publicado: (2022)

Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist
por: duPont, Nefertiti Chianti, et al.
Publicado: (2010)

Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer
por: Yang, Linlin, et al.
Publicado: (2020)

Partial ablation of endometrial glands in dogs after exposure to progestin during the neonatal period
por: Teixeira, Natália Soares, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_04gk0r4evsjg1c59661nqrqr5q